In a mouse model of melanoma, increased effectiveness of anti-PD-L1 therapy was associated with enhanced Bifidobacterium (Bifidobacterium longum and B. breve) abundance in the gut and a consequent activation of dendritic cells (Sivan et al., 2015). This evidence concerns the gene CD274 and melanoma.